Back
G1 Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
GTHX
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
38
GTHX
G1 Therapeutics
Last Price:
3.99
Seasonality Move:
16.06%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.G1 Therapeutics Price Quote
$3.99
G1 Therapeutics Key Stats
Sell
38
G1 Therapeutics (GTHX)
is a Sell
Day range:
$3.84 - $4.05
52-week range:
$1.08 - $5.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.62
P/B ratio:
5.89%
Volume:
441.5K
Avg. volume:
782.2K
1-year change:
62.2%
Market cap:
$208.3M
Revenue:
$82.5M
EPS:
$-0.95
How Much Does G1 Therapeutics Make?
-
How Much Are G1 Therapeutics's Sales Annually?
GTHX Revenues are $82.5M -
How Much Profit Does G1 Therapeutics's Make A Year?
GTHX net income is -$48M
Is G1 Therapeutics Growing As A Company?
-
What Is G1 Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.45% -
What Is G1 Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
G1 Therapeutics Stock Price Performance
-
Did G1 Therapeutics Stock Go Up Last Month?
G1 Therapeutics share price went down by -6.99% last month -
Did GTHX's Share Price Rise Over The Last Year?
GTHX share price rose by 62.2% over the past 1 year
What Is G1 Therapeutics 52-Week High & Low?
-
What Is G1 Therapeutics’s 52-Week High Share Price?
G1 Therapeutics has traded as high as $5.00 over the past 52 weeks -
What Is G1 Therapeutics’s 52-Week Low Share Price?
G1 Therapeutics has traded as low as $1.08 over the past 52 weeks
G1 Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy G1 Therapeutics?
-
How Much Debt Does G1 Therapeutics Have?
Total long term debt quarterly is $51.6M -
How Much Cash Does G1 Therapeutics Have?
Cash and short term investments quarterly total is $82.2M -
What Is G1 Therapeutics’s Book Value Per Share?
Book value per share is 0.68
Is G1 Therapeutics Cash Flow Positive?
-
What Is GTHX Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.3M -
What Is G1 Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$26.9M -
What Is G1 Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $2.8M
G1 Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
GTHX return on invested capital is -42.99% -
What Is G1 Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -31.87% -
What Is GTHX Return On Equity?
ROE is a measure of profitability and is -96.05%
G1 Therapeutics Earnings Date & Stock Price
-
What Is G1 Therapeutics's Stock Price Today?
A single share of GTHX can be purchased today for 3.99 -
What Is G1 Therapeutics’s Stock Symbol?
G1 Therapeutics trades on the nasdaq under the ticker symbol: GTHX -
When Is G1 Therapeutics’s Next Earnings Date?
The next quarterly earnings date for G1 Therapeutics is scheduled on May 1, 2024 -
When Is GTHX's next ex-dividend date?
G1 Therapeutics's next ex-dividend date is May 20, 2020 -
How To Buy G1 Therapeutics Stock?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
G1 Therapeutics Competitors
-
Who Are G1 Therapeutics's Competitors?
Below is a list of companies who compete with G1 Therapeutics or are related in some way:
G1 Therapeutics Dividend Yield
Data Unavailable
G1 Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 19.23% |
Revenue: | 45.1% | 14.17% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 8.50 |
Upside from Last Price: | 113.03% |